US Patent 11485958 HSD17B13 variants and uses thereof
Patent 11485958 was granted and assigned to Regeneron Pharmaceuticals on November, 2022 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
July 29, 2020
Date of Patent
November 1, 2022
Patent Applicant
Patent Application Number
16942386
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 11485958 HSD17B13 variants and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
